Noam E. Kopmar
Impact in
-
- Cancer-related molecular mechanisms research
-
- RNA modifications and cancer
- RNA and protein synthesis mechanisms
- RNA Research and Splicing
- Cancer-related gene regulation
- RNA regulation and disease
Papers in
-
- Acute Lymphoblastic Leukemia research 6
- Oncology 4
- CAR-T cell therapy research 4
- Co-authors
- Cristian Bellodi (3 shared papers)Davide Ruggero (3 shared papers)Sharmishtha Musalgaonkar (1 shared paper)Arturas Meškauskas (1 shared paper)Jonathan D. Dinman (1 shared paper)Sunnie R. Thompson (1 shared paper)Rachel O. Niederer (1 shared paper)Dori M. Landry (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Blood (2 papers)Molecular Cell (1 paper)Cell Reports (1 paper)Cancer Management and Research (1 paper)
- Partner nations
- United StatesLithuaniaAustralia
In The Last Decade
Noam E. Kopmar
11 papers receiving 571 citations
Peers
Comparison fields: 5 of 43
- Cancer Research 131
- Molecular Biology 488
- Oncology 84
- Hematology 31
- Physiology 44
Countries citing papers authored by Noam E. Kopmar
This map shows the geographic impact of Noam E. Kopmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noam E. Kopmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noam E. Kopmar more than expected).
Fields of papers citing papers by Noam E. Kopmar
This network shows the impact of papers produced by Noam E. Kopmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noam E. Kopmar. The network helps show where Noam E. Kopmar may publish in the future.
Co-authors
The 25 scholars most cited alongside Noam E. Kopmar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 257 | |
| 2 | 2010 | 142 | |
| 3 | 2013 | 111 | |
| 4 | 2022 | 28 | |
| 5 | 2023 | 8 | |
| 6 | 2024 | 8 | |
| 7 | New drug approvals in acute myeloid leukemia: an unprecedented paradigm shift. | 2019 | 8 |
| 8 | 2024 | 5 | |
| 9 | 2025 | 4 | |
| 10 | 2024 | 3 | |
| 11 | 2017 | 1 | |
| 12 | 2024 | 0 | |
| 13 | 2023 | 0 |
About Noam E. Kopmar
Noam E. Kopmar is a scholar working on Public Health, Environmental and Occupational Health, Oncology, Molecular Biology, Hematology and Physiology, having authored 13 papers that have together received 575 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (6 papers), CAR-T cell therapy research (4 papers), Acute Myeloid Leukemia Research (2 papers), Telomeres, Telomerase, and Senescence (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Lymphoma Diagnosis and Treatment (2 papers), RNA regulation and disease (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (131 citations), Molecular Biology (488 citations), Oncology (84 citations), Hematology (31 citations) and Physiology (44 citations). Noam E. Kopmar has collaborated with scholars based in United States, Lithuania and Australia. Frequent co-authors include Cristian Bellodi, Davide Ruggero, Sharmishtha Musalgaonkar, Arturas Meškauskas, Jonathan D. Dinman, Sunnie R. Thompson, Rachel O. Niederer, Dori M. Landry, Ryan D. Cassaday and Akiko Shimamura. Their work appears in journals such as Journal of Clinical Oncology, Blood, Molecular Cell, Cell Reports and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.